Inovio Pharmaceuticals, Inc.Panjang
INO ready for new high
Telah dikemas kini
I have taken a long position in INO here.
INO is in human trials for covid-19 vaccine with safety results expected in late June. Multiple possible catalyst including further funding. NVAX just received $388 million from CEPI and with INO being one of the few in human trials for covid-19 vaccine already, further funding for INO is likely as well.
This is not a recommendation to buy.
This is not financial advice.
INO is in human trials for covid-19 vaccine with safety results expected in late June. Multiple possible catalyst including further funding. NVAX just received $388 million from CEPI and with INO being one of the few in human trials for covid-19 vaccine already, further funding for INO is likely as well.
This is not a recommendation to buy.
This is not financial advice.
Nota
Not turning out like I planned so far. Still on high watch. Only a matter of time imo.Dagangan ditutup: sasaran tercapai
Boomshakalaka
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.